204 related articles for article (PubMed ID: 25296600)
1. Serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a diagnostic and prognostic marker for non-small cell lung cancer.
Xu C; Yu LK; Zhang X
Tumori; 2014; 100(4):107e-11e. PubMed ID: 25296600
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients.
Giaginis C; Margeli A; Kouraklis G; Zira A; Tsourouflis G; Theocharis S
Int J Biol Markers; 2009; 24(2):70-6. PubMed ID: 19634109
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
4. The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers.
Coban S; Ozkan H; Köklü S; Yüksel O; Koçkar MC; Akar T; Ormeci N
Can J Gastroenterol; 2006 Sep; 20(9):593-6. PubMed ID: 17001401
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Clinical significance and prognostic value of serum RCAS1 in patients with non-small cell lung cancer.
Xu CH; Hao KK; Yu LK; Zhang XW
Int J Biol Markers; 2014 Oct; ():0. PubMed ID: 25362935
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1.
Iwasaki T; Nakashima M; Watanabe T; Yamamoto S; Inoue Y; Yamanaka H; Matsumura A; Iuchi K; Mori T; Okada M
Int J Cancer; 2000 Nov; 89(6):488-93. PubMed ID: 11102892
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
9. The clinical and pathological significance of RCAS1 expression as a prognostic biomarker in non-small cell lung cancer.
Tsoukalas N; Kostakis ID; Siakavellas S; Giaginis C; Bournakis E; Sfiniadakis I; Karameris A; Patsouris E; Theocharis S
In Vivo; 2014; 28(3):375-81. PubMed ID: 24815841
[TBL] [Abstract][Full Text] [Related]
10. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
[TBL] [Abstract][Full Text] [Related]
11. Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer.
Hu LA; Fu Y; Zhang DN; Zhang J
Asian Pac J Cancer Prev; 2013; 14(4):2563-6. PubMed ID: 23725175
[TBL] [Abstract][Full Text] [Related]
12. RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung.
Oizumi S; Yamazaki K; Nakashima M; Watanabe T; Hommura F; Ogura S; Nishimura M; Dosaka-Akita H
Oncology; 2002; 62(4):333-9. PubMed ID: 12138241
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
14. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
[TBL] [Abstract][Full Text] [Related]
15. CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy.
Sone K; Oguri T; Nakao M; Kagawa Y; Kurowaka R; Furuta H; Fukuda S; Uemura T; Takakuwa O; Kanemitsu Y; Ohkubo H; Takemura M; Maeno K; Ito Y; Sato H; Muramatsu H; Niimi A
Anticancer Res; 2017 Feb; 37(2):935-939. PubMed ID: 28179355
[TBL] [Abstract][Full Text] [Related]
16. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of RCAS1 as a biomarker of uterine cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
[TBL] [Abstract][Full Text] [Related]
18. Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases.
Ozkan H; Akar T; Köklü S; Coban S
Pancreatology; 2006; 6(4):268-72. PubMed ID: 16636598
[TBL] [Abstract][Full Text] [Related]
19. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.
Akashi T; Oimomi H; Nishiyama K; Nakashima M; Arita Y; Sumii T; Kimura T; Ito T; Nawata H; Watanabe T
Pancreas; 2003 Jan; 26(1):49-55. PubMed ID: 12499917
[TBL] [Abstract][Full Text] [Related]
20. Receptor-binding cancer antigen expressed on SiSo cells (RCAS1): a novel biomarker in the diagnosis and prognosis of human neoplasia.
Giaginis C; Giagini A; Theocharis S
Histol Histopathol; 2009 Jun; 24(6):761-76. PubMed ID: 19337974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]